arXivDaily arXiv每日学术速递 周一至周五更新
arXiv 2502.00568cs.CVcs.AIcs.LG

从癌症组织病理学生成跨模态基因表达以提高多模态AI预测

Generating crossmodal gene expression from cancer histopathology improves multimodal AI predictions

School of Mathematical & Computational Sciences, Indian Association for the Cultivation of Science(数学与计算科学学院,印度科学培养协会);The Alan Turing Institute(艾伦·图灵研究所);Comprehensive Cancer Center, King’s College London(国王学院综合癌症中心);Department of Computer Science and Engineering, Jadavpur University(计算机科学与工程系,贾瓦德pur大学);MRC Biostatistics Unit, University of Cambridge(剑桥大学医学研究委员会生物统计学单位);Department of Biostatistics, Bioinformatics and Biomathematics, Georgetown University(生物统计学、生物信息学与生物数学系,杰斐逊大学);UCL Cancer Institute, Dept of Medical Physics & Biomedical Engineering, University College London(伦敦大学学院癌症研究所,医学物理与生物医学工程系)

Samiran Dey, Christopher R. S. Banerji, Partha Basuchowdhuri, Sanjoy K. Saha, Deepak Parashar, Tapabrata Chakraborti

AI总结:

PathGen通过生成跨模态基因表达提升癌症分级和生存风险预测的多模态AI性能

摘要:

新兴研究强调,基于人工智能的数字病理学与转录组特征的多模态融合可以提高癌症诊断(分级/亚型)和预后(生存风险)预测。然而,这种直接融合在临床环境中并不现实,因为在公共医疗中,组织病理学仍是金标准,转录组检测很少被要求。我们在此在两个公开可用的多模态数据集上进行实验,即癌症基因组图谱和临床蛋白质肿瘤分析联盟,涵盖四个独立队列:胶质瘤-胶母瘤、肾、子宫和乳腺,并观察到在整合合成转录组数据与WSI时,在分级和风险估计方面有显著的性能提升(p值<0.05)。此外,使用合成特征进行的预测在统计上接近使用真实转录组数据获得的预测(p值>0.05),在各队列中保持一致。在此,我们展示了通过我们的基于扩散的跨模态生成AI模型PathGen,从数字组织病理学中合成的基因表达共同预测癌症分级和患者生存风险,具有高准确性(最先进的性能)、确定性(通过符合覆盖率保证)和可解释性(通过分布式共注意图)。PathGen代码可在GitHub上公开使用,网址为https://github.com/Samiran-Dey/PathGen。

英文摘要:

Emerging research has highlighted that artificial intelligence-based multimodal fusion of digital pathology and transcriptomic features can improve cancer diagnosis (grading/subtyping) and prognosis (survival risk) prediction. However, such direct fusion is impractical in clinical settings, where histopathology remains the gold standard and transcriptomic tests are rarely requested in public healthcare. We experiment on two publicly available multimodal datasets, The Cancer Genomic Atlas and the Clinical Proteomic Tumor Analysis Consortium, spanning four independent cohorts: glioma-glioblastoma, renal, uterine, and breast, and observe significant performance gains in gradation and risk estimation (p-value<0.05) when incorporating synthesized transcriptomic data with WSIs. Also, predictions using synthesized features were statistically close to those obtained with real transcriptomic data (p-value>0.05), consistently across cohorts. Here we show that with our diffusion based crossmodal generative AI model, PathGen, gene expressions synthesized from digital histopathology jointly predict cancer grading and patient survival risk with high accuracy (state-of-the-art performance), certainty (through conformal coverage guarantee) and interpretability (through distributed co-attention maps). PathGen code is available for open use on GitHub at https://github.com/Samiran-Dey/PathGen.

机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。

↑